Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade.

Michele Moschetta Mario UccelloBenjamin KasendaGabriel MakAnissa McClellandStergios BoussiosMartin ForsterHendrik-Tobias Arkenau

Published in: BioMed research international (2017)

Changes in the NLR may be a useful predicting factor in advanced cancer patients treated with anti-PD-1/PD-L1 agents. Further prospective trials are needed to verify these findings.

Keyphrases

advanced cancer
palliative care
peripheral blood
metabolic syndrome
adipose tissue
weight loss